重药控股跌2.01%，成交额2.08亿元，主力资金净流出181.31万元

Core Viewpoint - The stock of Chongqing Pharmaceutical Holdings Co., Ltd. has experienced fluctuations, with a recent decline of 2.01% and a year-to-date increase of 18.69% [1] Group 1: Stock Performance - As of December 25, the stock price is reported at 6.35 yuan per share, with a total market capitalization of 10.974 billion yuan [1] - The stock has seen a 7.43% decline over the last five trading days, but a 20.72% increase over the last 20 days and a 24.27% increase over the last 60 days [1] - The company has appeared on the "龙虎榜" (a stock trading leaderboard) twice this year, with the latest instance on December 15, where it recorded a net purchase of 1.58 billion yuan [1] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 62.211 billion yuan, reflecting a year-on-year growth of 4.22% [2] - The net profit attributable to shareholders for the same period was 384 million yuan, showing a significant year-on-year increase of 31.41% [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders has decreased by 4.05% to 42,000, while the average circulating shares per person increased by 4.22% to 41,112 shares [2] - The company has distributed a total of 864 million yuan in dividends since its A-share listing, with 294 million yuan distributed over the last three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 10.091 million shares, an increase of 851,000 shares compared to the previous period [3]